News
The Hindu BusinessLine
Feb 25, 2024
Eyestem’s promising pipeline of products catches the eye of traditional pharma companies
Two pharmaceutical companies and a vaccine-maker invested in Eyestem (2022), putting the spotlight on the cell therapy company’s product pipeline. The six-year old company’s potential therapy for dry age-related macular degeneration, a global unmet medical need, awaits regulatory approvals in India for trial in humans, even as the company prepares to take the investigational new drug to Australia, says Eyestem co-founder and Chief Executive Jogin Desai.
The Hindu BusinessLine
Jan 24, 2024
AquaExchange raises $6 m in Series A
AquaExchange, an aquaculture technology and fintech start-up, has raised $6 million in Series A funding led by Ocean 14 Capital with participation from existing investors including Endiya Partners and Accion Venture Lab.
VC Circle
Jan 9, 2024
Fintech Platform Grip Invest Snags $10 Mn From Multiple Investors in Series B Round
Fixed income investment platform Grip Invest has raised Rs 82 crore (around $10 million) in a Series B funding round. The round which saw a mix of equity and debt investments was led by venture debt firm Stride Ventures. The startup raised Rs 70 crore in equity funding, while the remaining Rs 12 crore was debt.
Economic Times
Oct 31, 2023
Healthtech startup Sugar.fit secures $11 million in round led by MassMutual Ventures
Sugar.fit, a healthtech startup that seeks to manage and reverse type 2 and pre-diabetes, on Tuesday said it has raised $11 million in a Series A funding round led by MassMutual Ventures. Other participating investors include Cure.fit, Tanglin Venture Partners, and Endiya Partners.
2022 All rights reserved
